Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults by Karina A. Pasquevich, Lorena M. Coria, Ana Ceballos, Bianca Mazzitelli, Juan Manuel Rodriguez, Agostina Demaría, Celeste Pueblas Castro, Laura Bruno, Lucas Saposnik, Melina Salvatori, Augusto Varese, Soledad González, Veronica V. González Martínez, Jorge Geffner, Diego Álvarez, Laboratorio Pablo Cassará R&D and CMC for ARVAC CG consortium, Ethel Feleder, Karina Halabe, Pablo E. Perez Lera, Federico Montes de Oca, Julio C. Vega, Mónica Lombardo, Gustavo A. Yerino, Juan Fló, Juliana Cassataro

Get full text